Abonnement à la biblothèque: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publication de 6  numéros par an

ISSN Imprimer: 0743-4863

ISSN En ligne: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Polymer-Drug Conjugates for Anticancer Drug Delivery

Volume 32, Numéro 3, 2015, pp. 215-245
DOI: 10.1615/CritRevTherDrugCarrierSyst.2015010174
Get accessGet access

RÉSUMÉ

Polymer-drug conjugates (PDCs) are drug delivery systems where one or more drug(s) are covalently attached to the functional groups of the polymer directly or through a spacer. Several anticancer drugs that have been used to synthesize PDCs are currently under clinical trials. PDCs have shown enhanced tumor accumulation, increased therapeutic index, and prolonged circulation, accompanied by a sustained release of the bound drug. Distinct cell uptake mechanisms make PDCs less sensitive to efflux pumps associated with the development of multi-drug resistance. However, the effectiveness of PDCs as a delivery system primarily depends on the drug, polymer, type of linkage, and presence of targeting groups. Due to the availability of different functional groups and spacers, it is possible to control drug release as well as multi-functionalize PDCs, thereby increasing their versatility as drug carriers. Furthermore, active tumor uptake may be achieved by using the concept of drug targeting. However, functionalization alters the in vivo behavior of the polymer, signifying the evaluation of safety and effectiveness of PDCs. Several PDCs are currently being tested in different phases of clinical trials. This review focuses on critical aspects in the design of PDCs when used in cancer drug delivery.

CITÉ PAR
  1. Kurniawan Alfin, Gunawan Farrel, Nugraha Adi Tama, Ismadji Suryadi, Wang Meng-Jiy, Biocompatibility and drug release behavior of curcumin conjugated gold nanoparticles from aminosilane-functionalized electrospun poly( N -vinyl-2-pyrrolidone) fibers, International Journal of Pharmaceutics, 516, 1-2, 2017. Crossref

  2. Sun Qihang, Zhou Zhuxian, Qiu Nasha, Shen Youqing, Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization, Advanced Materials, 29, 14, 2017. Crossref

  3. Zhang Ruinian, Jia Xu, Pei Mingliang, Liu Peng, Facile preparation of pH/reduction dual-responsive prodrug microspheres with high drug content for tumor intracellular triggered release of DOX, Reactive and Functional Polymers, 116, 2017. Crossref

  4. Bhattarai Prashant, Vance Dylan, Hatefi Arash, Khaw Ban An, Anin vitrodemonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugates, Journal of Drug Targeting, 25, 5, 2017. Crossref

  5. Khan Junaid, Alexander Amit, Ajazuddin , Saraf Swarnlata, Saraf Shailendra, Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections, International Journal of Pharmaceutics, 548, 1, 2018. Crossref

  6. Xiao Haihua, Yan Lesan, Dempsey Elizabeth M., Song Wantong, Qi Ruogu, Li Wenliang, Huang Yubin, Jing Xiabin, Zhou Dongfang, Ding Jianxun, Chen Xuesi, Recent progress in polymer-based platinum drug delivery systems, Progress in Polymer Science, 87, 2018. Crossref

  7. Seifu Muluneh Fromsa, Nath Lila Kanta, Polymer-Drug Conjugates: Novel Carriers for Cancer Chemotherapy, Polymer-Plastics Technology and Materials, 58, 2, 2019. Crossref

  8. Hu Yingwen, Stevens David M., Man Sonny, Crist Rachael M., Clogston Jeffrey D., Total drug quantification in prodrugs using an automated elemental analyzer, Drug Delivery and Translational Research, 9, 6, 2019. Crossref

  9. Gupta Swati, Pathak Yashwant, Gupta Manish K., Vyas Suresh P., RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted, Artificial Cells, Nanomedicine, and Biotechnology, 47, 1, 2019. Crossref

  10. Dzhardimalieva Gulzhian I., Rabinskiy Lev N., Kydralieva Kamila A., Uflyand Igor E., Recent advances in metallopolymer-based drug delivery systems, RSC Advances, 9, 63, 2019. Crossref

  11. Mukaya Elie Hembe, Mbianda Xavier Yangkou, Macromolecular Prodrugs Containing Organoiron-Based Compounds in Cancer Research: A Review, Mini-Reviews in Medicinal Chemistry, 20, 9, 2020. Crossref

  12. Desai Kashappa Goud H., Polymeric drug delivery systems for intraoral site‐specific chemoprevention of oral cancer, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 106, 3, 2018. Crossref

  13. Rizwanullah Md., Amin Saima, Mir Showkat Rasool, Fakhri Khalid Umar, Rizvi Mohd. Moshahid Alam, Phytochemical based nanomedicines against cancer: current status and future prospects, Journal of Drug Targeting, 26, 9, 2018. Crossref

  14. Mansur Alexandra A. P., Carvalho Sandhra M., Lobato Zélia I. P., Leite Maria de Fátima, Cunha Armando da Silva, Mansur Herman S., Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy, Bioconjugate Chemistry, 29, 6, 2018. Crossref

  15. Li Yihui, Hu Hang, Zhou Qing, Ao Yanxiao, Xiao Chen, Wan Jiangling, Wan Ying, Xu Huibi, Li Zifu, Yang Xiangliang, α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery, ACS Applied Materials & Interfaces, 9, 22, 2017. Crossref

  16. Jeong Young-IL, Yoo So Young, Heo Jeong, Kang Dae Hwan, Chlorin e6-Conjugated and PEGylated Immune Checkpoint Inhibitor Nanocomposites for Pulmonary Metastatic Colorectal Cancer, ACS Omega, 4, 20, 2019. Crossref

  17. Wang Yaoqi, Xia Heming, Chen Binlong, Wang Yiguang, Rethinking nanoparticulate polymer–drug conjugates for cancer theranostics, WIREs Nanomedicine and Nanobiotechnology, 2022. Crossref

  18. Ezazi-Toroghi Sara, Ali Sana Abdul-Jabbar, Bokov Dmitry Olegovich, Dareini Maryam, Bahadori Malihe, Mokaberi Parisa, Amiri-Tehranizadeh Zeinab, Saberi Mohammad Reza, Chamani Jamshidkhan, Interaction behavior between glycated human serum albumin and metformin in the presence of silver nanoparticles: a combination study of spectroscopic, calorimetric and molecular dynamic, Journal of the Iranian Chemical Society, 2022. Crossref

  19. McCartin Conor, Dussouillez Candice, Bernhard Chloé, Mathieu Eric, Blumberger Juliette, Dontenwill Monique, Herold-Mende Christel, Idbaih Ahmed, Lavalle Philippe, Bellemin-Laponnaz Stéphane, Kichler Antoine, Fournel Sylvie, Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells, Cancers, 14, 20, 2022. Crossref

  20. Mansur Alexandra A. P., Carvalho Sandhra M., Oliveira Luiz Carlos A., Souza-Fagundes Elaine Maria, Lobato Zelia I. P., Leite Maria F., Mansur Herman S., Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells, Pharmaceutics, 14, 10, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain